Page last updated: 2024-11-09

loline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

loline: RN given from CAS Index Guide (1982-1986), p.1019G [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

loline : A loline alkaloid with formula C8H14N2O. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID716098
CHEBI ID156448
SCHEMBL ID395725
MeSH IDM0165440

Synonyms (23)

Synonym
25161-91-5
loline
2,4-methano-4h-furo(3,2-b)pyrrol-3-amine, hexahydro-n-methyl-, (2r,3r,3as,4s,6as)-
festucine
2,4-methano-4h-furo(3,2-b)pyrrole, hexahydro-3-(methylamino)-
2,4-methano-4h-furo(3,2-b)pyrrol-3-amine, hexahydro-n-methyl-, (2r-(2-alpha,3-alpha,3a-beta,4-alpha,6a-beta))-
CHEBI:156448
lolina
(1s,6r,7r,7as)-n-methylhexahydro-1h-1,6-epoxypyrrolizin-7-amine
AKOS006278760
unii-ic997t2wz9
ic997t2wz9 ,
loline [mi]
methyl-n-depropionyldecorticasine
(+)-loline
(2r,3r,3as,4s,6as)-hexahydro-n-methyl-2,4-methano-4h-furo(3,2-b)pyrrol-3-amine
SCHEMBL395725
(2r,3r,3as,4s,6as)-hexahydro-n-methyl-2,4-methano-4h-furo[3,2-b]pyrrol-3-amine
(1r,3s,7s,8r)-n-methyl-2-oxa-6-azatricyclo[4.2.1.0,3,7]nonan-8-amine
Q27280662
XL175852
(1r,3s,7s,8r)-n-methyl-2-oxa-6-azatricyclo[4.2.1.0?,?]nonan-8-amine
(1r,3s,7s,8r)-n-methyl-2-oxa-6-azatricyclo[4.2.1.03,7]nonan-8-amine

Research Excerpts

Overview

Loline (1) is a small alkaloid that, in spite of its simple-looking structure, has posed surprising challenges to synthetic chemists. The lolines are a class of bioprotective alkaloids that are produced by Epichloë species.

ExcerptReferenceRelevance
"The lolines are a class of bioprotective alkaloids that are produced by Epichloë species, fungal endophytes of grasses. "( Enzymes from fungal and plant origin required for chemical diversification of insecticidal loline alkaloids in grass-Epichloë symbiota.
Bhardwaj, M; Grossman, RB; Nagabhyru, P; Pan, J; Schardl, CL, 2014
)
1.18
"Loline (1) is a small alkaloid that, in spite of its simple-looking structure, has posed surprising challenges to synthetic chemists. "( An efficient synthesis of loline alkaloids.
Cakmak, M; Mayer, P; Trauner, D, 2011
)
2.11

Effects

ExcerptReferenceRelevance
"The loline alkaloids have been identified as possible target metabolites as they are associated with potent effects on insects and low toxicity to grazing animals."( Short-term toxicity studies of loline alkaloids in mice.
Finch, SC; Kerby, JW; Munday, JS; Munday, R, 2016
)
1.2

Treatment

ExcerptReferenceRelevance
"The loline treatment caused no statistically significant effect on gross pathology, histology, haematology, blood chemistry, heart rate, blood pressure or motor coordination."( Short-term toxicity studies of loline alkaloids in mice.
Finch, SC; Kerby, JW; Munday, JS; Munday, R, 2016
)
1.2

Toxicity

ExcerptReferenceRelevance
" The success of this approach is dependent on the selection of an appropriate secondary metabolite target which must not only be effective against insect pests but also be safe for grazing and monogastric animals."( Short-term toxicity studies of loline alkaloids in mice.
Finch, SC; Kerby, JW; Munday, JS; Munday, R, 2016
)
0.72

Dosage Studied

The total quantity of lolines excreted in both urine and faeces was 10% and 4% of the amount dosed in Experiments 1 and 2, respectively.

ExcerptRelevanceReference
"To determine the effect of oral dosing of sheep with loline alkaloids on their excretion in urine and faeces, and to monitor for any toxic effects."( Excretion of loline alkaloids in urine and faeces of sheep dosed with meadow fescue (Festuca pratensis) seed containing high concentrations of loline alkaloids.
Fletcher, LR; Gooneratne, SR; Patchett, BJ; Wellby, M, 2012
)
1
" The total quantity of lolines excreted in both urine and faeces was 10% and 4% of the amount dosed in Experiments 1 and 2, respectively."( Excretion of loline alkaloids in urine and faeces of sheep dosed with meadow fescue (Festuca pratensis) seed containing high concentrations of loline alkaloids.
Fletcher, LR; Gooneratne, SR; Patchett, BJ; Wellby, M, 2012
)
1.06
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
secondary amino compoundA compound formally derived from ammonia by replacing two hydrogen atoms by organyl groups.
loline alkaloidA pyrrolizidine alkaloid that is hexahydro-1H-pyrrolizine carrying an exo-1-amino group at position 1 and an ether bridge between C-2 and C-7. It is a class of natural insecticides produced by fungal symbionts of Poaceae.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (46)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.17)18.7374
1990's8 (17.39)18.2507
2000's17 (36.96)29.6817
2010's17 (36.96)24.3611
2020's3 (6.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.80 (24.57)
Research Supply Index3.89 (2.92)
Research Growth Index5.44 (4.65)
Search Engine Demand Index61.17 (26.88)
Search Engine Supply Index2.31 (0.95)

This Compound (38.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]